Verenium Corporation

Visual Financials
Company Name: Verenium Corporation
Ticker Symbol: VRNM
CIK Number: 0001049210
WWW Address: www.verenium.com
CEO: James E. (Jamie) Levine
No. of Employees: 111
Common Issue Type: CS
Business Description:Verenium Corporation is an industrial biotechnology company, which develops and commercializes high performance enzymes for use in industrial processes.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 3.99 Unchanged 0.0 - -  3.99 3.99 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.0 0.0 0.00  0.00 0.0 0.0 3.99 - 3.99
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close3.99$
PE Ratio - LTM0.0
Market Capitalisation0.0mil
Latest Shares Outstanding0.0mil
Earnings pS (EPS)$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee515,054$
Effective Tax Rate1.2%
Float0.0mil
Float as % of Shares Outstanding%
Foreign Sales39mil
Domestic Sales18mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS0.00$
Book-Value pS$
Tangible Book-Value pS0.00$
Cash Flow pS$
Free Cash Flow pS$
KEY FIGURES (LTM): Price info
Price/Book Ratio
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.01
4 Weeks3.993.993.990.01
13 Weeks3.993.993.990.0
26 Weeks3.993.993.990.0-5
52 Weeks3.993.993.990.0-11
YTD3.993.99-0.0-1
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
3.993.993.993.993.990.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.0
Income0.0
Dividend0.0
Capital SpendingNA
R&D-30.93NA-19.45
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-20.0-20.0-6.7
Earnings %-100.0-100.0255.2
EPS %-100.0-100.0243.9
EPS $-2.79-2.791.00
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio43.38
Current Ratio3.6
Quick Ratio (Acid Test)2.9
Liquidity Ratio (Cash)2.39
Receivables Turnover5.2
Average Collection Period69
Working Capital/Equity132.7
Working Capital pS3.18
Cash-Flow pS1.60
Free Cash-Flow pS0.85
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.12
Financial Leverage Ratio (Assets/Equity)3.1
Debt Ratio67.3
Total Debt/Equity (Gearing Ratio)1.53
LT Debt/Equity1.53
LT Debt/Capital Invested61.3
LT Debt/Total Liabilities74.3
Interest Cover9.9
Interest/Capital Invested2.67
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-3.54
Enterprise Value (EV)/Free Cash Flow1.83
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM1.6
P/E Ratio (52 weeks ago) - LTM1.4
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS3.67
Current Liabilities pS1.22
Tangible Book Value pS - LTM0.00
Book Value pS - LTM
Capital Invested pS0.00
Cash pS - LTM0.00
Cash Flow pS - LTM
Free Cash Flow pS - LTM
Earnings pS (EPS)
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin18.94
Free Cash Flow Margin 5YEAR AVG-68.33
Net Profit Margin31.9
Net Profit Margin - 5YEAR AVRG.
Equity Productivity1.87
Return on Equity (ROE)59.4
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity0.74
Return on Capital Invested (ROCI)23.5
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity0.70
Return on Assets (ROA)19.4
Return on Assets (ROA) - 5YEAR AVRG.
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin32.4
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate1.2
Effective Tax Rate - 5YEAR AVRG.6.9
EFFICIENCY RATIOS
Cash Conversion Cycle137
Revenue per Employee515,054
Net Income per Employee164,081
Average Collection Period67
Receivables Turnover5.2
Day's Inventory Turnover Ratio70
Inventory Turnover5.1
Inventory/Sales9.3
Accounts Payble/Sales13.25
Assets/Revenue1.43
Net Working Capital Turnover1.41
Fixed Assets Turnover1.53
Total Assets Turnover0.7
Revenue per $ Cash1.64
Revenue per $ Plant1.55
Revenue per $ Common Equity1.87
Revenue per $ Capital Invested0.74
Selling, General & Adm/tive (SG&A) as % of Revenue34.2
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue26.3
R&D Expense as % of Revenue - 5YEAR AVRG.26.3

  


Your Recent History
NASDAQ
VRNM
Verenium C..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.